Saturday, 19 September 2020

Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda

The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...

from NDTV News - Topstories https://ift.tt/2FMnI1j
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Trump's Team Wanted To Ban Voting Machines In Half Of US Last Year: Report

White House adviser Kurt Olsen, a lawyer Trump has tasked with proving widely debunked election-rigging conspiracy theories, pushed the plan...